Evidence map›Paper›PMID 40214766›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2026

Co-occurrence of parkinson disease and multiple sclerosis - a critical note.

Kurt A Jellinger

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kurt A JellingerInstitute of Clinical Neurobiology, Alberichgasse 5/13, Vienna, A-1150, Austria. kurt.jellinger@univie.ac.at.ORCID http://orcid.org/0000-0002-9641-7649

Funding

Society for the Promotion of Research in Experimental Neurology, Vienna, Austria Society for the Promotion of Research in Experimental Neurology, Vienna, Austria
6 · The paper itself

Abstract

While multiple sclerosis (MS) is associated with various movement disorders, in particular tremor and ataxia, its combination with parkinsonism is rare and co-occurrence of MS and Parkinson disease (PD) has been reported in only few definite cases. Theories about this co-occurrence range from coincidental to causal, but the true prevalence, basic features and causal relations between the two entities have not been systemically evaluated. Although there are cases of causal relationship between parkinsonism and MS related to demyelinating lesions affecting the dopaminergic nigrostriatal pathway, in a limited number of cases, PD (some gene-mediated) and MS may coexist as two separate diseases in the same patients. The prevalence of MS in LRRK2 PD, while rare, supports an important role for immune function in both disorders, while the role of PD-related PINK is still open. Furthermore, several common genes such as BACE2, CD69, CLC, CPA3 and DEFAs may play important roles in MS and PD, while MS and PD share iron accumulation in substantia nigra, which may be due to protein-protein interaction networks related to metal homeostasis. In view of the various pathogenic possibilities, the causal relationship of concurring MS and PD deserves critical consideration.

Indexed as

Multiple SclerosisParkinson DiseaseHumansCommon LRRK2 expressionGene mutationsMultiple sclerosisParkinson disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.